Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial - Davies, C; Pan, H; Godwin, J; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group (Lancet, 2013)